Search for: "ACTAVIS"
Results 281 - 300
of 1,005
Sorted by Relevance
|
Sort by Date
15 Aug 2019, 11:16 am
Actavis Laboratories FL, Inc. [read post]
4 Dec 2014, 5:00 am
Bruce H. [read post]
14 Mar 2012, 10:00 pm
Nous avions vu le mois dernier que la CJUE avait été saisie d'une question préjudicielle relative à l'interprétation des articles 4 et 5 du règlement sur les CCP. [read post]
12 Aug 2014, 9:55 pm
Both these assumptions are thrown into doubt by the Patent Court's decision in Actavis v Eli Lilly[2]. [read post]
1 Jul 2013, 9:59 pm
Actavis, Inc. and Mutual Pharmaceutical Co. v. [read post]
11 Oct 2013, 9:34 pm
The American Bar Association (ABA) Section of Intellectual Property Law, Young Lawyers Division, and Center for Professional Development will be offering a live webinar on "Reverse-Payment License Agreements: A Review of the Hatch-Waxman Act Post-Actavis" on October 22, 2013 from 2:00 to 3:30 pm (Eastern). [read post]
30 Dec 2012, 9:30 pm
Actavis Inc. 1:12-cv-01750; filed December 21, 2012 in the District Court of Delaware Infringement of U.S. [read post]
9 Sep 2014, 9:59 pm
Actavis, in this action the Commission has expanded its allegations of anticompetitive behavior beyond cash payments from branded to generic drug companies (provocatively termed "pay-for-delay" agreements) to other forms of agreements (and not for the first time). [read post]
10 Jun 2014, 5:25 pm
., Actavis, Inc., Watson Laboratories,Inc., and Watson Pharma, Inc. [read post]
30 Sep 2013, 4:50 am
Mark Lemley's Firm Files DJ Against Myriad in Northern California ----- Promise Not to Infringe Insufficient in ANDA Litigation ----- Licensing Deals Stall in Pharmaceutical Sector in First Half of 2013 ----- Mylan Settles with FTC over Agila Acquisition from Strides ----- Amgen and ShanghaiTech University Announce China R&D Center ----- Forest Laboratories sues over SAVELLA® generics ----- Teva Pharmaceutical scores patent cictory over Mylan on AZILECT® ----- Patent Awarded to New… [read post]
13 Mar 2016, 7:00 am
Actavis has given the FTC a greater capacity to challenge pay for delay schemes in court. [read post]
11 Apr 2015, 8:45 pm
Sandoz and the Impact of a New Claim Construction Standard of Review • Personal and General Jurisdiction Challenges Under Daimler and Mylan • Myriad 101 Rejections and Nautilus 112 Indefiniteness Findings • Barraclude and New Obviousness Considerations • IPR, CBM, and PGR Utilization in ANDA Litigation • Reissue Applications as a Cure for Invalidity Findings • Akamai's Effect on Method of Treatment Claims and Carve-Outs • Settlement Strategies… [read post]
5 Feb 2019, 9:59 pm
They also found that even if the claims had been found valid, they would not have been infringed by Actavis and Mylan's activities, and that the post-trial amendment to try to limit the... [read post]
25 Feb 2020, 9:03 am
Actavis Laboratories UT, Inc., with Judges Newman, O’Malley, Stoll and Lourie dissenting. [read post]
31 Mar 2019, 7:48 pm
Actavis Laboratories FL, Inc.). [read post]
7 Dec 2017, 9:34 pm
., Actavis Laboratories UT, Inc., FKA Watson Laboratories Inc., Lupin Pharmaceuticals, Inc. and Lupin Ltd., and Amneal Pharmaceuticals LLC filed... [read post]
22 Aug 2013, 9:59 pm
Actavis), the Federal Trade Commission has filed an amicus curiae brief with the District Court of New Jersey in In re Effexot XR Antitrust Litigation. [read post]
16 May 2014, 9:45 pm
The conference will provide optimal strategies to help attendees maximize their patent portfolios, including: • The radical SPC decisions in Georgetown University, Actavis and Eli Lilly; • Capitalise on second medical use patents by implementing proven strategies and utilising tactical enforcement and remedial methods; • Fundamental update on the imminent Unitary Patent and Unified Patent Court and how to adapt business strategies effectively; • The 'Right' to… [read post]
27 Feb 2013, 9:41 pm
Actavis Inc. et al. [read post]
12 Oct 2020, 9:59 pm
Noonan -- The Federal Trade Commission carried out an (in)famous crusade against reverse payment (more provocatively, "pay for delay") settlements in ANDA litigation for almost a decade before eventually having the Supreme Court see things their way (to some extent) in FTC v Actavis. [read post]
